THRD: Third Harmonic Bio Inc. Kompaniya qiymatining sof foydaga nisbati
Third Harmonic Bio (THRD) aktivlar qiymatining -4.60 metriki bilan ko'rsatilgan ushbu grafigi yallig'lanishga qarshi agentlarni ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi. Hozirgi vaqtda narxlar ustidan nazorat mastotsitozni nishonga oluvchi dori vositalarining sinov natijalariga bog'liq. Biroq, selektiv KIT ingibitorlari dermatitni davolash imkonini beradi, bu esa talabni elastik emas qiladi. Mast hujayralarini bostiruvchi molekulalarning eksklyuzivligi urtikariya terapiyasida inqilobiy yutuq va sezilarli narx belgilash imkoniyatini va'da qiladi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_THRD_-_Third-Harmonic-Bio_-_PE-Multiple "THRD: Third Harmonic Bio Biznesning o‘zini qoplash muddati 28.04.2023 - 16.08.2025 | 👁️GURU.Markets👁️")
Third Harmonic Bio, Inc (THRD) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Third Harmonic Bio|THRD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Third Harmonic Bio Inc|THRD - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Third Harmonic Bio, Inc.|THRD - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Third Harmonic Bio|Oraliq likvidlik koeffitsiyenti thirdharmonicbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
THRD - Sof foyda|Kutilayotgan sof daromad Third Harmonic Bio|THRD - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Third Harmonic Bio Inc.|THRD - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Third Harmonic Bio, Inc.|THRD - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun foyda Third Harmonic Bio|THRD - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi thirdharmonicbio.com|THRD - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Third Harmonic Bio
Kompaniyaning har tomonlama tahlili:thirdharmonicbio.com THRD
Third Harmonic Bio (THRD) faoliyat yuritadigan biofarmatsevtika sektori uchun P/E baholash dinamikasi kelajakdagi daromadlar bo'yicha bozor kutganlarini aks ettiradi. Ushbu ko'rsatkich aksiyaning joriy narxining bir aksiya uchun foyda miqdoriga nisbati sifatida hisoblanadi. Mazkur metrika investor daromadning har bir dollari uchun qanchalik ortiqcha to'lov qilayotganini aniqlaydi. Kompaniyaning barqaror pul oqimi va nazorat qilingan xarajatlar sur'ati (burn rate) ushbu nisbatning tebranishlarini yumshatadi. Grafik tahlili aktivlarning haddan tashqari qizigan yoki past baholangan bosqichlarini o'z vaqtida aniqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL: Narx-foyda koeffitsiyenti|Tourmaline - Bozor narxining sof foydaga nisbati|PGEN: P/E multiplikatori|pharming.com - Kompaniya qiymatining sof foydaga nisbati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Upstream Bio, Inc. (UPB) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|KALV: Narx-foyda multiplikatori|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA: P/E multiplikatori|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|P/E multiplikatori astriatx.com|Narxning foydaga nisbati enGene (ENGN)|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|ACRS - Narx-foyda koeffitsiyenti|KYTX - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati tizianalifesciences.com|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Narx-foyda multiplikatori VTYX|THTX (Theratechnologies Inc) - P/E multiplikatori|Avalo Therapeutics Inc (AVTX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|Climb Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ZURA|aTyr - P/E multiplikatori|ADAG: Narxning foydaga nisbati|IMA: P/E multiplikatori|STTK - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Equillium Inc|Kapitalizatsiyaning foydaga nisbati Connect Pharma CNTB|Narx-foyda koeffitsiyenti IMUX (Immunic, Inc.)|Bozor narxining sof foydaga nisbati ATRA|P/E multiplikatori IFRX (InflaRx)|Kompaniya qiymatining sof foydaga nisbati XFOR|ACET - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CELU (Celularity Inc.)|INMB: P/E multiplikatori|Narx-foyda multiplikatori BRNS|Narxning foydaga nisbati Kezar Life Sciences|sabbiotherapeutics.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori AKTX|ENLV (enlivex.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|P/E multiplikatori GeoVax Corp GOVX|EDSA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati IBIO (ibioinc.com)|carismatx.com (CARM) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti XTL Biopharmaceuticals Ltd|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|P/E multiplikatori HCW Biologics Inc|Narx-foyda koeffitsiyenti APVO (Aptevo Therapeutics)|AIM (AIM ImmunoTech, Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADTX (Aditxt, Inc.)|Biznesning o‘zini qoplash muddati GRI Bio Inc (GRI)|XRTX - Narxning foydaga nisbati|Vyome Therapeutics (HIND) - Narx-foyda koeffitsiyenti|Revelation Biosciences (REVB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti indaptusrx.com|Narx-foyda koeffitsiyenti SCNI|P/E multiplikatori CalciMedica Corp|Narxning foydaga nisbati Affimed (AFMD)|allakos.com - Narx-foyda multiplikatori|P/E multiplikatori HOOK (HOOKIPA Pharma)|IGM Biosciences Inc. (IGMS) - Kapitalizatsiyaning foydaga nisbati|ITOS: Narx-foyda koeffitsiyenti|Ocean Biomedical Inc - Bozor narxining sof foydaga nisbati|TCBP: P/E multiplikatori
